Khalil Asmar is Vice President for Cardiometabolic Health and Business Unit Leader for the Northern Europe Hub at Eli Lilly and Company. With nearly two decades at Lilly, he has built a wide-ranging career spanning pricing, market access, and corporate affairs across the Middle East, Gulf region, SAMETA, International Business Unit and the UK — most recently serving as Associate Vice President for Pricing, Reimbursement and Access in the Northern Europe Hub. In his current role, Khalil leads the commercial strategy for one of the most dynamic and fast-evolving therapeutic areas in global healthcare. He holds a Bachelor's degree in Computer and Information Science from Notre Dame University, Lebanon, and is currently a candidate for Executive MBA at London Business School as part of the Class of 2026.